NCT02172950 An Open-label Safety and Efficacy Study of Recombinant FVIII in Patients With Severe Hemophilia A Status COMPLETED Phase PHASE3
NCT02061072 Web-based Application for the Population Pharmacokinetic Service - Phase 1 Status COMPLETED Phase N/A
NCT02061033 Global Hemostatic Methods in Hemophilia and Von Willebrand's Disease Status UNKNOWN Phase N/A
NCT02035605 A Phase 1 Study of an Investigational Drug, ALN-AT3SC, in Healthy Volunteers and Hemophilia A or B Patients Status COMPLETED Phase PHASE1
NCT02027779 Safety and Efficacy Extension Study of GreenGene™ F in Previously Treated Patients Diagnosed With Severe Hemophilia A Status UNKNOWN Phase PHASE3
NCT01959919 Evaluation Of Acceptability And Satisfaction Of Hemophilia Patients Treated With FusENGO Status COMPLETED Phase N/A
NCT01921855 Study of FVIIa Variant BAY86-6150 (B0189) in Subjects With Moderate or Severe Hemophilia Types A or B With or Without Inhibitors Status COMPLETED Phase PHASE1
NCT01913405 Phase 3 Efficacy and Safety Study of BAX 855 in Severe Hemophilia A Patients Undergoing Surgical Procedures Status COMPLETED Phase PHASE3
NCT01810666 Prophylaxis Versus on Demand Treatment for Children With Hemophilia A Status COMPLETED Phase PHASE4
NCT01790828 Post Marketing Surveillance To Observe Safety And Efficacy Of Xyntha® In Subjects With Hemophilia A Status COMPLETED Phase N/A
NCT01775618 Safety and Efficacy of BAY94-9027 in Previously Treated Male Children With Haemophilia A Status COMPLETED Phase PHASE3
NCT01757405 Recombinant Factor VIIa BI (rFVIIa BI) Treatment of Acute Bleeding Episodes Per an On-demand Regimen Status COMPLETED Phase PHASE3
NCT01748201 Viscosupplementation in Patients With Hemophilic Arthropathy Status COMPLETED Phase PHASE4
NCT01736475 Study Investigating a PEGylated Recombinant Factor VIII (BAX 855) for Hemophilia A (PROLONG-ATE Study) Status COMPLETED Phase PHASE2/PHASE3
NCT01653639 Comparative Pharmacokinetic Study of Two Different Strengths of BAY14-2222 Status COMPLETED Phase PHASE1